Clinical Trials Logo

Awake Endotracheal Intubation clinical trials

View clinical trials related to Awake Endotracheal Intubation.

Filter by:
  • None
  • Page 1

NCT ID: NCT06026566 Recruiting - Remimazolam Clinical Trials

Compatible Effect of Remimazolam Besylate Combined With Afentanil for ATI

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

1. To study the pharmacokinetics between remimazolam besylate and alfentanil; 2. To determine the optimal dosage of the two drugs in awake endotracheal intubation; 3. To provide clinical guidance for awake endotracheal intubation.

NCT ID: NCT01848548 Terminated - Clinical trials for Difficult Intubation

Superior Laryngeal Nerve Block For Awake Endotracheal Intubation Study

Start date: April 2013
Phase: N/A
Study type: Observational

Awake tracheal intubation is the standard management for patients as risk for airway compromise. It is also commonly done in cases where there is significant cervical spine pathology i.e. cervical myelopathy or instability. The anesthetic technique used for the awake intubation is crucial to the patient's safety. One of the most important aspects of the anesthetic technique is airway anesthesia prior to placement of an endotracheal tube. The superior laryngeal nerve is responsible for mediating the cough reflex around the vocal cords. The investigators have developed an approach to reliably block the superior laryngeal nerve by injecting local anesthetic near the nerve in a unique approach. Injecting local anesthetic into or through the thyrohyoid membrane will effectively block the superior laryngeal nerve